Drug
AC 225 Psma 62
AC 225 Psma 62: highest development phase Phase 1, developed by Eli Lilly. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Eli Lilly
Trials
| Drug | Phase | Indication |
|---|---|---|
| [Ac-225]-PSMA-62 (mCRPC) NCT06229366 | Phase 1 | Prostate Cancer |
Latest
No recent events.
Follow AC 225 Psma 62 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.